Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (161-170 of 340) with videos related to

Pageof 34
Sort By:
Journal of Crohn'S & Colitis|April 21, 2016
DNA Damage and Oxidative DNA Damage in Inflammatory Bowel DiseaseCristiana Pereira, Rosa Coelho, Daniela Grácio, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-AnalysisFernando Magro, Maria Manuela Estevinho, Cláudia Camila Dias, et al.
Journal of Crohn'S & Colitis|March 6, 2025
Higher dietary glycemic index, but not glycemic load, is associated with increased risk of ulcerative colitis: a prospective cohort studyShuyu Ye, Tian Fu, Yiwen Tu, et al.
Immunobiology|January 29, 2011
Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infectionNair Campos, Fernando Magro, Ana Rita Castro, et al.
Clinical and Translational Gastroenterology|March 11, 2021
Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel DiseasePedro Pinto-Lopes, Francisco Melo, Joana Afonso, et al.
Inflammatory Bowel Diseases|November 20, 2023
Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn's Disease: A Propensity Score-Matched AnalysisSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
Nature Reviews. Gastroenterology & Hepatology|May 19, 2026
Precision nutrition for the prevention and management of inflammatory bowel diseaseJie Chen, Lintao Dan, Judith Wellens, et al.
Clinical and Translational Gastroenterology|March 29, 2022
Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World?Mafalda Santiago, Francisco Stocker, Paula Ministro, et al.
Inflammatory Bowel Diseases|August 10, 2024
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference StudyJavier P Gisbert, Stefan Schreiber, Corey A Siegel, et al.
United European Gastroenterology Journal|December 14, 2023
Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's diseaseSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
Pageof 34

Showing results (161-170 of 340) with videos related to

Sort By:
Pageof 34
Journal of Crohn'S & Colitis|April 21, 2016
DNA Damage and Oxidative DNA Damage in Inflammatory Bowel DiseaseCristiana Pereira, Rosa Coelho, Daniela Grácio, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-AnalysisFernando Magro, Maria Manuela Estevinho, Cláudia Camila Dias, et al.
Journal of Crohn'S & Colitis|March 6, 2025
Higher dietary glycemic index, but not glycemic load, is associated with increased risk of ulcerative colitis: a prospective cohort studyShuyu Ye, Tian Fu, Yiwen Tu, et al.
Immunobiology|January 29, 2011
Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infectionNair Campos, Fernando Magro, Ana Rita Castro, et al.
Clinical and Translational Gastroenterology|March 11, 2021
Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel DiseasePedro Pinto-Lopes, Francisco Melo, Joana Afonso, et al.
Inflammatory Bowel Diseases|November 20, 2023
Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn's Disease: A Propensity Score-Matched AnalysisSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
Nature Reviews. Gastroenterology & Hepatology|May 19, 2026
Precision nutrition for the prevention and management of inflammatory bowel diseaseJie Chen, Lintao Dan, Judith Wellens, et al.
Clinical and Translational Gastroenterology|March 29, 2022
Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World?Mafalda Santiago, Francisco Stocker, Paula Ministro, et al.
Inflammatory Bowel Diseases|August 10, 2024
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference StudyJavier P Gisbert, Stefan Schreiber, Corey A Siegel, et al.
United European Gastroenterology Journal|December 14, 2023
Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's diseaseSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
Pageof 34